FollowMyHealth Patient Portal

Erik Richard Dubberke, MD

Associate Professor, Medicine
Division of Infectious Diseases

Specialty Areas

Infectious Diseases
Oncology

Board Certifications

Internal Medicine
Infectious Diseases

Hospital Affiliations

Barnes-Jewish Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients,  infections in cancer patients

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Taylor Ave. Building Extension

620 South Taylor Ave.
Suite 100
St. Louis, MO 63110

Office Phone: 314-747-1206
Fax: 314-222-6252

Education

Education

Residency: Washington University School of Medicine, St. Louis, Missouri 2002
Medical Degree: University of Illinois at Chicago College of Medicine, Rockford, Illinois 1999
B.A.: Augustana College, Rock Island, Illinois 1995

Publication & Research

Publication & Research

Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System.
Escobar GJ, Baker JM, Kipnis P, Greene JD, Mast TC, Gupta SB, Cossrow N, Mehta V, Liu V, Dubberke ER
Infect Control Hosp Epidemiol. 2017 Oct; 38(10)1196-1203. doi: 10.1017/ice.2017.176.

PMID:
    28835289
    [PubMed - in process]
Related citations


Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to <i>Clostridium difficile</i> Virulence.
Lewis BB, Carter RA, Ling L, Leiner I, Taur Y, Kamboj M, Dubberke ER, Xavier J, Pamer EG
MBio. 2017 Aug 8; 8(4)pii: e00885-17. doi: 10.1128/mBio.00885-17.

PMID:
    28790208
    [PubMed - in process]
Related citations


Reducing Fluoroquinolone Use Is a Key Step in Controlling the Burden of Clostridium difficile Infection.
Walker T, Ciorba M, Dubberke ER
Gastroenterology. 2017 Aug; 153(2)606-607. doi: 10.1053/j.gastro.2017.06.048.

PMID:
    28668696
    [PubMed - in process]
Related citations


Assessment of Healthcare Worker Protocol Deviations and Self-Contamination During Personal Protective Equipment Donning and Doffing.
Kwon JH, Burnham CD, Reske KA, Liang SY, Hink T, Wallace MA, Shupe A, Seiler S, Cass C, Fraser VJ, Dubberke ER
Infect Control Hosp Epidemiol. 2017 Sep; 38(9)1077-1083. doi: 10.1017/ice.2017.121.

PMID:
    28606192
    [PubMed - in process]
Related citations


Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study.
Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Benedict K, Murphy K, Pappas PG
Open Forum Infect Dis. 2017 Spring; 4(2)ofx050. doi: 10.1093/ofid/ofx050.

PMID:
    28491889
    [PubMed]
Related citations


Risk for <i>Clostridium difficile</i> Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period.
Dubberke ER, Reske KA, Olsen MA, Bommarito KM, Seiler S, Silveira FP, Chiller TM, DiPersio J, Fraser VJ
Transplant Direct. 2017 Apr; 3(4)e145. doi: 10.1097/TXD.0000000000000662.

PMID:
    28405601
    [PubMed]
Related citations


Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB, MODIFY I and MODIFY II Investigators.
N Engl J Med. 2017 Jan 26; 376(4)305-317. doi: 10.1056/NEJMoa1602615.

PMID:
    28121498
    [PubMed - indexed for MEDLINE]
Related citations


Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.
Slade M, Goldsmith S, Romee R, DiPersio JF, Dubberke ER, Westervelt P, Uy GL, Lawrence SJ
Transpl Infect Dis. 2017 Feb; 19(1)doi: 10.1111/tid.12629.

PMID:
    28030755
    [PubMed - indexed for MEDLINE]
Related citations


Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
Kwon JH, Reske KA, Hink T, Burnham CA, Dubberke ER
J Clin Microbiol. 2017 Feb; 55(2)596-605. doi: 10.1128/JCM.02126-16.

PMID:
    27927930
    [PubMed - indexed for MEDLINE]
Related citations


Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.
Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Dubberke ER, Trinkaus K, Romee R
Haematologica. 2016 Nov; 101(11)e465-e468.

PMID:
    27443287
    [PubMed - in process]
Related citations


Clearance of Vancomycin-Resistant <i>Enterococcus</i> Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent <i>Clostridium difficile</i> Infection.
Dubberke ER, Mullane KM, Gerding DN, Lee CH, Louie TJ, Guthertz H, Jones C
Open Forum Infect Dis. 2016 Sep; 3(3)ofw133.

PMID:
    27703995
    [PubMed]
Related citations


An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients.
Kwon JH, Lanzas C, Reske KA, Hink T, Seiler SM, Bommarito KM, Burnham CD, Dubberke ER
Infect Control Hosp Epidemiol. 2016 Dec; 37(12)1401-1407.

PMID:
    27691986
    [PubMed - in process]
Related citations


Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C
J Natl Compr Canc Netw. 2016 Jul; 14(7)882-913.

PMID:
    27407129
    [PubMed - in process]
Related citations


Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.
Gupta SB, Mehta V, Dubberke ER, Zhao X, Dorr MB, Guris D, Molrine D, Leney M, Miller M, Dupin M, Mast TC
Clin Infect Dis. 2016 Sep 15; 63(6)730-734. doi: 10.1093/cid/ciw364.

PMID:
    27365387
    [PubMed - in process]
Related citations


Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
Desai K, Gupta SB, Dubberke ER, Prabhu VS, Browne C, Mast TC
BMC Infect Dis. 2016 Jun 18; 16303. doi: 10.1186/s12879-016-1610-3.

PMID:
    27316794
    [PubMed - indexed for MEDLINE]
Related citations


The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.
Olsen MA, Young-Xu Y, Stwalley D, Kelly CP, Gerding DN, Saeed MJ, Mahé C, Dubberke ER
BMC Infect Dis. 2016 Apr 22; 16177. doi: 10.1186/s12879-016-1501-7.

PMID:
    27102582
    [PubMed - indexed for MEDLINE]
Related citations


Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.
Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP
Emerg Infect Dis. 2016 Apr; 22(4)608-16. doi: 10.3201/eid2204.150455.

PMID:
    26982504
    [PubMed - indexed for MEDLINE]
Related citations


Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.
Dubberke ER, Olsen MA, Stwalley D, Kelly CP, Gerding DN, Young-Xu Y, Mahé C
PLoS One. 2016; 11(2)e0146822. doi: 10.1371/journal.pone.0146822.

PMID:
    26859403
    [PubMed - indexed for MEDLINE]
Related citations


Clostridium difficile-Diagnostic and Clinical Challenges.
Burnham CA, Dubberke ER, Kociolek LK, Polage CR, Riley TV
Clin Chem. 2016 Feb; 62(2)310-4. doi: 10.1373/clinchem.2015.243717.

PMID:
    26656133
    [PubMed - indexed for MEDLINE]
Related citations


Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PUNCH CD Investigators.
Clin Infect Dis. 2016 Mar 1; 62(5)596-602. doi: 10.1093/cid/civ938.

PMID:
    26565008
    [PubMed - indexed for MEDLINE]
Related citations

Notes

Financial Disclosure: Dr. Dubberke’s income from Merck was >$10k in 2014 due to an accounting error by Merck in 2013.  

Areas of Research Interest

Clostridium-difficile infection, infections in transplant and oncology patients